Dr. Terry Dubrow Reveals the Unexpected Ozempic “Perk” Men Keep Reporting — Inside the Celebrity Surgeon’s Surprising New Observation
Dr. Terry Dubrow has never been one to shy away from uncomfortable conversations, whether in the operating room, on television, or behind a microphone. But even longtime fans of the Botched star didn’t expect him to tease a brand-new, eyebrow-raising side effect linked to Ozempic — the immensely popular semaglutide medication originally designed for Type 2 diabetes but now widely used for weight loss. During the November 24 episode of Between Us, the candid podcast he co-hosts with his wife Heather Dubrow, the plastic surgeon revealed that men on Ozempic are experiencing a “perk” that he never anticipated.
In typical Dubrow fashion, he delivered the revelation with a mix of humor and clinical honesty, telling listeners that upcoming discussions about Ozempic are only becoming more complex as doctors continue to learn what the drug can do. “I have an announcement,” he said, half teasing and half serious. “There’s a new Ozempic-related disorder.” The statement immediately caught the attention of his audience, who’ve grown accustomed to his frank take on medical trends. But this time, it was the nature of the “disorder” itself that made his comment so surprising — because it wasn’t a warning. It was a benefit.
According to Dubrow, male patients have begun reporting an unexpected physiological improvement after starting semaglutide: a noticeable boost in sexual function. And though sexual health is a topic Dubrow approaches with scientific distance, he acknowledged that the effect seems to be occurring frequently enough to warrant discussion. While he did not frame the observation as a universal or proven medical claim, he presented it as part of a larger trend forming around Ozempic’s expanding profile. As patients continue to come forward about everything from appetite changes to shifts in mood and energy, one of the more unexpected stories emerging is that some men are seeing an increase in sexual performance or libido.
Dubrow was careful to keep the tone light, but he didn’t dismiss the reports. Instead, he placed them in the context of how semaglutide affects the body. Ozempic works by mimicking GLP-1, a naturally occurring hormone that regulates blood sugar and slows digestion. Its primary outcome is appetite suppression, weight loss, and improved metabolic stability — but those benefits can indirectly influence other bodily systems. As Dubrow explained, when men lose weight, lower inflammation, and see improvements in cardiovascular health, their sexual health can improve as well. “When your metabolic health gets better, a lot of other things can get better too,” he noted.
But what caught his attention was that several men were reporting changes earlier than expected — sometimes even before major weight loss took place. Dubrow said he doesn’t yet have a scientific explanation for why this might happen. Instead, he emphasized that the anecdotal experiences point to an area worth researching. For now, he considers it part of a growing list of unexpected Ozempic-related observations that doctors are hearing in real time, long before formal studies catch up with real-world experiences.
Still, Dubrow made it clear that the sudden popularity of semaglutide comes with responsibilities. He has consistently reminded listeners that Ozempic is a prescription drug meant to treat specific medical conditions, not a cosmetic quick fix. Its rapid rise into mainstream culture — boosted by celebrities, influencers, and online trends — has made it one of the most talked-about pharmaceuticals in recent memory. But for Dubrow, the primary concern remains safety. He emphasized that anyone considering the medication should use it under the guidance of a licensed medical professional, not based on viral trends or informal advice circulating online.
He also acknowledged that Ozempic is still a relatively new player in the widespread weight-loss landscape, and long-term side effects are still being studied. That’s part of why he and Heather spend so much time on their podcast breaking down what the science says — and what it doesn’t yet say. The unexpected “perk” he mentioned fits neatly into this category. Dubrow was quick to clarify that no one should begin Ozempic for anything other than its FDA-approved purposes. He urged listeners to avoid making assumptions or generalizations, and reminded them that individual experiences vary widely.
Heather, who often serves as the voice of balance on their show, chimed in with her own questions, pressing Dubrow to explain whether the reports represent a true side effect or simply the result of improved health overall. She noted that many men using Ozempic are already taking steps to reduce weight, improve mobility, stabilize blood pressure, and make healthier lifestyle choices — all factors that contribute naturally to better sexual performance. Dubrow agreed that the correlation is complicated. “The body is interconnected,” he said. “When one system improves, you can see positive changes in others.”
He laughed, but he didn’t avoid the subject. Instead, he used the opportunity to remind listeners of an often-overlooked truth: sexual health is tied closely to overall physical health. It’s no surprise, scientifically, that people who lose weight, reduce insulin spikes, and improve circulation may feel better in areas beyond what they originally set out to address. Dubrow stressed, however, that sexual performance should never be viewed as a guaranteed effect of any medication. The reports he’s heard remain anecdotal, not clinical.
Still, his comments have already sparked widespread interest, partly due to how openly he addressed a topic many shy away from. The revelation has also added yet another layer to Ozempic’s cultural moment — a moment that shows no signs of slowing. The drug has swept through Hollywood, digital media, and everyday medical practices. Its influence extends far beyond weight loss, shaping conversations around body image, diet culture, prescription ethics, medical shortages, and long-term health outcomes.
Dubrow’s remarks underscore how many unanswered questions remain about semaglutide. He has previously discussed concerns about misuse, especially among individuals who do not meet the medical criteria for the drug. He has urged caution around compounding pharmacies and unofficial sources distributing semaglutide products, noting the risks associated with unregulated dosages or formulations. The new “perk” he mentioned is not something he celebrates as a selling point but rather another piece of information in the ongoing effort to understand the medication fully.
Ozempic’s rise has been so rapid that even longtime doctors say they are learning alongside their patients. And while most of the conversation focuses on weight loss, Dubrow believes it’s equally important to highlight the broader changes patients are describing — whether positive or negative. “Medicine evolves,” he said. “Our understanding evolves with it.”
By bringing fresh public attention to this unexpected observation, Dubrow has, intentionally or not, opened the door for more nuanced research into how semaglutide affects the body as a whole. For now, he describes the discovery in the same tone he uses to describe most new medical curiosities: with a blend of scientific curiosity and cautious realism.
As Ozempic continues to dominate headlines and treatment plans, Dubrow’s comments add yet another dimension to the ongoing conversation. It may be years before studies confirm or reject what men are reporting — but for now, the celebrity surgeon has once again found himself at the center of the discussion, shedding light on the mysteries and surprises of a drug that has reshaped modern weight-loss treatment in ways few anticipated.
Whether this “unexpected perk” becomes a recognized side effect or remains a footnote in Ozempic’s story, one thing is clear: the cultural, medical, and personal implications of semaglutide are much bigger than any single benefit. And as long as people continue to share their experiences, Terry Dubrow will likely continue sharing his unfiltered, medically grounded take — exactly the kind of voice listeners turn to when the conversation grows complicated.
